Jonathan Silver, MD
Clinical Cardiac Electrophysiology · Burlington, MANPI 1033153176
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $62,406 of the $101,536 with a category attached, or 61.5%. 10 manufacturers reported payments, led by Abbott at 51.0% of the total.
Across 269 payments — averaging $377.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$52K
- Boston Scientific$29K
- Medtronic$10K
- Atricure, Inc.$7K
- Altathera Pharmaceuticals LLC$1K
- Biosense Webster, Inc.$1K
- plus $1K from 4 others
Across 59 payments — averaging $423.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$22K
- Atricure, Inc.$3K
What the payments were for
- Consulting fees$19,67519%
- Speaking & faculty fees$62,40661%
- Travel & lodging$9,95510%
- Food & beverage$9,4999%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 128 | $51,776 |
| Boston Scientific | 90 | $29,423 |
| Medtronic(2 entities) | 32 | $9,762 |
| Atricure, Inc. | 3 | $7,200 |
| Altathera Pharmaceuticals LLC | 2 | $1,350 |
| Biosense Webster, Inc. | 2 | $1,009 |
| Biotronik Inc. | 4 | $445 |
| Edwards Lifesciences | 1 | $325 |
| Philips North America LLC | 1 | $150 |
| Novartis | 6 | $95 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$30,519
- ENSITE$9,527
- VersaCross Large Access Solution$8,750
- Watchman$7,550
- NA$6,736
- GENERAL EP$5,469
- GENERAL - THERAPIES$2,815
- Farapulse$2,682
- Sotalol Hydrochloride$1,350
- AVEIR$1,230
- Carto 3$1,009
- WATCHMAN FLX$433
- AFFERA MAPPING SYSTEM$320
- Ensite Cardiac Mapping System$287
- CryoConsole$253
- TactiCath Quartz CFA Catheter$179
- VersaCross RF Wire$174
- Bridge$150
- Rhythmia Mapping System$148
- Zero Gravity$147
How this compares
$101,536 in reported general payments places this provider in the 80th percentile of 106 clinical cardiac electrophysiology providers in Massachusetts.
See all clinical cardiac electrophysiology providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 42 | $31,570 |
| XareltoRivaroxaban | 16 | $18,002 |
| Flecainide Acetate | 27 | $1,530 |
| Amiodarone Hcl | 29 | $551 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $323 |
| Metoprolol Succinate | 13 | $237 |
| Warfarin Sodium | 14 | $162 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Burlington
- Matthew ReynoldsBurlington$217K
- Bruce HookBurlington$68K
- Ghulam ChaudhryBurlington$15K
- Guy KulbakBurlington$15K
- Elad AnterBoston$3.9M
- Nitesh SoodFall River$668K
- Jagmeet SinghBoston$619K
- Andre DavilaBoston$379K
- Kevin FloydWorcester$278K
- Daniel KramerBoston$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.